GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.

Revenue
+7.19%
EPS
+40.6%
Free cash flow
+64.2%
Total debt
−1.90%

Quarter to September 2026, against a year earlier

82.39 1.36 −1.62%
Market cap
$37.9B
P/E
17.5×
Fwd P/E
15.5×
Dividend yield
0.17%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100

GE HealthCare Technologies Inc. (GEHC) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, GE HealthCare Technologies Inc. (GEHC) trades at a price to free cash flow of 19.9×. Over the past ten years it has ranged from 13.9× (January 2023) to 36.0× (December 2022); the current reading is higher than 30% of that period. That is below the Medical Devices industry median of 28.8× and below the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 24.9× 8.33%
FY2024 22.9× 13.22%
FY2023 20.3× 45.68%
FY2022 13.9× (61.40%)
FY2021 36.0× 0.00%
FY2020 36.0× 0.00%
FY2019 36.0× —

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 15.6× (14.82%)
Jun 2026 18.4× (14.06%)
Mar 2026 21.4× (14.02%)
Dec 2025 24.9× 1.59%
15 more quarters

Against its own ten years

Low 13.9× High 36.0×
Ten-year median 21.6×
Current reading's percentile 30

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 7.1×
PHG Koninklijke Philips N.V. compare 14.1×
ZBH Zimmer Biomet Holdings, Inc. compare 18.2×
BSX Boston Scientific Corporation compare 19.3×
GEHC GE HealthCare Technologies Inc. 19.9×
STE STERIS plc compare 26.4×
DXCM DexCom, Inc. compare 28.8×
EW Edwards Lifesciences Corporation compare 41.5×
GKOS Glaukos Corporation compare 360×
Medical Devices industry median 28.8×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on GEHC